N 1. Streptococcus***: Streptococcus pyogens infection - non-suppurative sequelae; non-suppurative complications*; S. Pneumonia and S. Viridans - differentiate* (8 differences) 2. Clostridium******: Clostridium botulinum infection - pathogenicity, prevention; Gas gangrene**** - pathogenesis**, laboratory diagnosis; Immunoprophylaxis of Tetanus; Nagler Reaction** - principle, procedure, use 3. Salmonella**: Salmonella Typhi - Enteric Fever - laboratory diagnosis; Widal Test; Laboratory Tests to diagnose Enteric Fever in first week, Co-Agglutination Test - role in diagnosis 4. Neisseria: Non-gonococcal Urethritis [NIGU] 5. Staphylococcus*: staphylococcal wound infection - laboratory diagnosis; Staphylococcus aureus - four diseases, staphylococcal food poisoning - describe 6. Corynebacterium diphtheria*: Diphtheria - pathogenicity; Metachromatic Granules; Toxigenicity Tests 7. Vibrio cholerae****: - Gardner and Venkataraman's classification; Classical vibrios and El Tor vibrios - differences**; Laboratory Diagnosis*; Halophilic Vibrios* - describe, two examples, Kanagawa Phenomenon* 8. Chlamydia trachomatis**: four diseases*, laboratory diagnosis of any one of them; Differentiate Chlamydia from virusus, Serotype 2 MBBS REFER APURB SHASTRI MUHS EXAM ORITNTED detail answer of questions diagrams as well

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File

answer

Here is the complete, MUHS exam-oriented answer for all 8 topics, Serotype 2 MBBS level, based on Medical Microbiology 9e, Jawetz, and Apurb Shastri-style presentation.

MICROBIOLOGY - MUHS EXAM NOTES (Serotype 2 MBBS)


1. STREPTOCOCCUS

A. Streptococcus pyogenes - Non-Suppurative Sequelae

Non-suppurative (non-purulent) sequelae are immunological complications that occur after S. pyogenes infection, NOT due to direct bacterial invasion.

Two Major Non-Suppurative Sequelae:


1. Rheumatic Fever (RF)

Occurs after: Streptococcal pharyngitis (throat infection) - NOT skin infection
Latent period: 2-4 weeks after pharyngitis
Pathogenesis - Molecular Mimicry:
S. pyogenes pharyngitis
        |
M protein antigen stimulates antibody production
        |
Antibodies cross-react with:
  - Heart (sarcolemmal antigens) --> Carditis
  - Joints (synovial tissue)     --> Migratory polyarthritis
  - Brain (caudate nucleus)      --> Sydenham's chorea
  - Skin (subcutaneous tissue)   --> Nodules, Erythema marginatum
Jones Criteria (Diagnosis):
  • Major: Carditis, Polyarthritis, Chorea, Erythema marginatum, Subcutaneous nodules
  • Minor: Fever, raised ESR/CRP, prolonged PR interval
Prevention:
  • Primary prevention: Treat strep throat with penicillin within 9 days
  • Secondary prevention: Monthly benzathine penicillin (1.2 MU IM) for 5 years or until age 21

2. Acute Glomerulonephritis (AGN / PSGN)

Occurs after: Both pharyngitis AND skin infection (impetigo) - nephritogenic strains only
Nephritogenic M types: Type 12 (pharyngitis), Type 49 (impetigo)
Latent period:
  • After pharyngitis: 10-14 days
  • After pyoderma: 3-6 weeks
Pathogenesis:
S. pyogenes infection (nephritogenic strain)
        |
Streptococcal antigen (NAPlr/SPE-B) deposited in glomeruli
        |
Antigen-antibody complex formation (Type III hypersensitivity)
        |
Complement activation --> Inflammatory damage
        |
Hematuria, proteinuria, hypertension, oliguria
Lab Findings:
  • Elevated ASO titer (pharyngitis-associated)
  • Elevated anti-DNase B (skin-associated - MORE sensitive)
  • Low serum C3 complement
  • Hematuria ("cola-colored urine")

B. S. pneumoniae vs. S. viridans - 8 Differences

FeatureS. pneumoniaeS. viridans
1. MorphologyLancet-shaped diplococciCocci in chains
2. HemolysisAlpha (green) on blood agarAlpha or gamma (non-hemolytic)
3. Optochin sensitivitySENSITIVE (inhibited)RESISTANT (no inhibition)
4. Bile solubilitySOLUBLE (lyses in bile/deoxycholate)INSOLUBLE
5. CapsulePolysaccharide capsule - PRESENT (major virulence)Usually absent or minimal
6. Inulin fermentationFerments inulin - POSITIVEDoes NOT ferment inulin
7. Mouse virulence (Quellung test)Virulent - causes fatal sepsis in miceAvirulent
8. Clinical diseasePneumonia, meningitis, otitis media, sinusitis - INVASIVESubacute bacterial endocarditis (SBE), dental caries - OPPORTUNISTIC
Memory tip: "OBIN" - Optochin, Bile solubility, Inulin, Neumoniae = Pneumoniae is POSITIVE for all

2. CLOSTRIDIUM

A. Clostridium botulinum - Pathogenicity & Prevention

Organism: Gram-positive, spore-forming, strict anaerobe; spores are oval, subterminal

Toxin (Pathogenicity):

Botulinum toxin = Most potent biological toxin known
  • Neurotoxin - blocks ACh release at neuromuscular junction
  • Produces flaccid (descending) paralysis
  • 7 types (A-G); Types A, B, E cause human disease
  • Type A most potent; Type E associated with fish/seafood
Mechanism:
Toxin ingested (preformed in food) / produced in vivo
        |
Toxin enters bloodstream
        |
Binds to presynaptic membrane of NMJ
        |
Cleaves SNARE proteins (synaptobrevin/SNAP-25)
        |
Blocks ACh vesicle fusion --> No ACh released
        |
FLACCID PARALYSIS (descending: diplopia --> dysphagia --> respiratory failure)
Types of Botulism:
  1. Food-borne: Preformed toxin in canned/preserved food (home-canned vegetables, fish)
  2. Wound: Toxin produced in contaminated wound
  3. Infant botulism: Most common - spores ingested (honey) --> colonize infant gut --> toxin produced in vivo ("floppy baby syndrome")
  4. Iatrogenic: Cosmetic/therapeutic misuse
Prevention:
  • Boiling food for 10 minutes before eating (destroys toxin - heat labile)
  • Pressure cooking destroys spores (121°C, 15 min)
  • Do NOT feed honey to infants under 1 year
  • Proper canning techniques (commercial canning)
  • Trivalent botulinum antitoxin (types A, B, E) for treatment/post-exposure

B. Gas Gangrene (Clostridial Myonecrosis)

Causative agent: Mainly C. perfringens Type A (80-90%); also C. novyi, C. septicum

Pathogenesis:

Traumatic wound with soil/fecal contamination
        |
C. perfringens spores germinate in anaerobic, ischemic tissue
        |
Produces ALPHA TOXIN (lecithinase/phospholipase C) [MAJOR VIRULENCE]
        |
Also: collagenase, hyaluronidase, DNase, theta toxin (perfringolysin O)
        |
Alpha toxin hydrolyzes membrane phospholipids
        |
Destruction of RBCs (hemolysis), muscle cells (myonecrosis)
        |
Gas production (H2, CO2) in tissues --> Crepitus
        |
Spreading necrosis, toxemia, systemic shock, DEATH
Alpha toxin is lecithinase - demonstrated by NAGLER REACTION (see below)
Clinical Features:
  • Severe pain at wound site (earliest symptom)
  • Crepitus on palpation (gas in tissue)
  • Brown/bronze discoloration of skin
  • Foul-smelling serous discharge ("dishwater" exudate)
  • Systemic toxemia: tachycardia, hypotension, jaundice

Laboratory Diagnosis of Gas Gangrene:

Specimen: Wound exudate, tissue biopsy
1. Gram Stain (Most rapid):
  • Large, rectangular, "box-car" shaped Gram-positive rods
  • Few or NO pus cells (toxin kills neutrophils)
  • Absence of spores (in tissue specimens)
2. Culture:
  • Robertson's cooked meat medium (anaerobic)
  • Blood agar (anaerobic): Double zone hemolysis (inner complete + outer partial)
  • Egg yolk agar: Nagler reaction positive (opalescent zone around colonies)
3. Nagler Reaction:
  • Half of egg yolk agar plate treated with anti-alpha toxin
  • C. perfringens produces opalescence on untreated half only
  • Inhibited on treated half = POSITIVE Nagler reaction
4. Sugar fermentation:
  • "Stormy clot/fermentation" in litmus milk: acid + gas = "stormy fermentation" (classic)
5. Biochemical tests:
  • Lecithinase positive
  • Lipase negative (differentiates from C. novyi)

C. Nagler Reaction - Principle, Procedure, Use

Principle:

C. perfringens produces alpha toxin (lecithinase C / phospholipase C) which splits lecithin (phosphatidylcholine) present in egg yolk into diglyceride + phosphorylcholine. This produces a white opalescent precipitate around colonies. Anti-alpha toxin (antitoxin) inhibits this reaction.

Procedure:

EGG YOLK AGAR PLATE
|___________________________|
| CONTROL SIDE | ANTITOXIN SIDE |
|              | (spread anti-alpha toxin) |
|              | Allow to absorb 30 min   |
|______________|___________________________|
        |
Inoculate C. perfringens across BOTH halves (single streak)
        |
Incubate anaerobically 37°C, 24-48 hrs
        |
RESULT:
Control side: Opalescent (pearly) zone around colonies
Antitoxin side: NO opalescence (inhibited)
= POSITIVE NAGLER REACTION

Use:

  1. Presumptive identification of C. perfringens
  2. Diagnosis of gas gangrene
  3. Differentiating C. perfringens from other clostridia
  4. Detecting lecithinase activity

D. Immunoprophylaxis of Tetanus

Causative agent: C. tetani (tetanospasmin neurotoxin)
Toxin mechanism: Blocks inhibitory neurotransmitter release (GABA, glycine) at Renshaw cells in spinal cord --> Spastic paralysis, risus sardonicus, opisthotonus

Active Immunization (DPT/Td Schedule - India):

DoseAgeVaccine
Primary 16 weeksDPT (or Pentavalent)
Primary 210 weeksDPT
Primary 314 weeksDPT
Booster 116-24 monthsDPT
Booster 25 yearsDT
TT10 yearsTT
TT16 yearsTT
  • Contains tetanus toxoid (formaldehyde-inactivated tetanospasmin)

Passive Immunization:

TypeAgentDoseWhen
Human Tetanus Immunoglobulin (HTIG)Homologous250-500 IU IMUnimmunized + tetanus-prone wound
Antitetanic Serum (ATS)Equine (heterologous)1500 IU IM/SCOnly if HTIG unavailable; do Schick test first

Wound Management (Post-exposure):

WOUND TYPE + IMMUNIZATION STATUS
         |
         |---> Clean, minor wound + >3 doses given --> NO prophylaxis needed
         |
         |---> Tetanus-prone wound (>6 hrs, crush, deep, dirty)
                    |
                    |---> Immunized (>3 doses) --> TT booster if >5 years
                    |---> NOT immunized --> TT + HTIG (different sites)

3. SALMONELLA

A. Salmonella Typhi - Enteric Fever - Laboratory Diagnosis

Specimen by Week:

WEEK 1: BLOOD CULTURE (most important, highest yield ~85-90%)
WEEK 2: BLOOD + URINE + WIDAL TEST
WEEK 3: STOOL + WIDAL TEST (peak titer)
WEEK 4: STOOL + URINE
Throughout: BONE MARROW (gold standard - 90% yield even after antibiotics)
MNEMONIC - "1 Blood, 2 Both, 3 Stool/Widal"

Blood Culture (Week 1 - Best):

  • 10-15 mL blood in 100 mL bile broth (1:10 ratio - dilutes bactericidal factors)
  • Incubate 37°C, subculture on MacConkey and blood agar at 24, 48, 72 hrs
  • Non-lactose fermenting (colorless/pale) colonies on MacConkey
  • H2S producing (black center) colonies on SS agar
  • Biochemical: TSI agar - Alkaline slant / Acid butt / H2S / Gas
  • Final confirmation: Serotyping with O, H, Vi antisera

Widal Test (Agglutination Test):

Principle: Patient's serum contains agglutinins against O (somatic) and H (flagellar) antigens of S. Typhi. Tests agglutination at serial dilutions.
Antigens tested:
  • S. Typhi O (TO) antigen
  • S. Typhi H (TH) antigen
  • S. Paratyphi A H (AH)
  • S. Paratyphi B H (BH)
Interpretation (India - endemic area):
  • Significant titer: O ≥ 1:160, H ≥ 1:160 (in endemic area)
  • Diagnostic (single sample): O ≥ 1:80 suggestive, H ≥ 1:160
  • Four-fold rise in titer in paired samples (10-14 days apart) = definitive
Widal Tube Agglutination:
  • O antibody: Granular, compact, heavy clumps - NOT dispersed on shaking
  • H antibody: Fluffy, cotton-wool clumps - DISPERSED on shaking
Limitations of Widal:
  • False positive: Other febrile illnesses, previous typhoid vaccination, malaria
  • False negative: Early disease, prior antibiotics
  • Cross-reactions with other Salmonella species

B. Laboratory Tests in FIRST WEEK of Enteric Fever:

TestSensitivityNotes
Blood culture85-90%Gold standard for Week 1
Bone marrow culture90%Best overall; not affected by antibiotics
Clot cultureGoodBlood clot after serum separated; bacteria in clot
Buffy coat cultureGoodWBC fraction; bacteria within monocytes
Widal testNOT useful in Week 1Antibodies not yet formed
PCRHigh (research)Detects S. Typhi DNA in blood
Typhidot IgMUseful from Day 3-4Detects IgM anti-S. Typhi OMP

C. Co-Agglutination Test (CoA Test)

Principle: Uses Cowan strain of Staphylococcus aureus (rich in Protein A) which binds to Fc region of IgG antibodies. Specific antibodies against S. Typhi antigens are coated on killed S. aureus. When patient's sample containing antigen is added, agglutination occurs - visible as clumping.
Protein A (on S. aureus) + Anti-Salmonella IgG (Fc binds to Protein A)
        |
Add patient's serum/urine/CSF (containing Salmonella antigen)
        |
Antigen-antibody reaction --> AGGLUTINATION = POSITIVE
Role in Diagnosis of Enteric Fever:
  • Detects S. Typhi antigen in blood, urine, CSF
  • Useful in Week 1 when antibodies (Widal) not yet formed
  • Can detect both Vi antigen and O antigen
  • Fast (result in 3-5 minutes)
  • More sensitive than Widal in early disease
  • Useful when patient has received antibiotics (culture may be negative)

4. NEISSERIA - Non-Gonococcal Urethritis (NGU/NIGU)

Definition: Urethritis NOT caused by Neisseria gonorrhoeae

Causative Organisms:

Organism% of NGUNotes
Chlamydia trachomatis (D-K)30-50%Most common
Ureaplasma urealyticum20-40%Mycoplasma-related
Mycoplasma genitalium15-25%Increasing importance
Trichomonas vaginalis5-10%Protozoan
HSVRareViral

Clinical Features:

  • Dysuria, urethral discharge (mucoid/mucopurulent, less than gonorrhea)
  • Discharge less profuse and less purulent than gonococcal urethritis
  • May be asymptomatic in males (especially Chlamydia)
  • In women: cervicitis, PID, infertility

Diagnosis:

  • Urethral swab: >5 PMNs/HPF (high power field) = urethritis
  • No gram-negative intracellular diplococci (GNID) = NGU (vs. gonorrhea)
  • NAAT (Nucleic Acid Amplification Test) for C. trachomatis/N. gonorrhoeae
  • Culture: negative for gonococcus

Treatment:

  • Azithromycin 1g single dose OR Doxycycline 100mg BD x 7 days
  • Treat partner simultaneously

5. STAPHYLOCOCCUS

A. Staphylococcal Wound Infection - Laboratory Diagnosis

Causative agent: S. aureus (coagulase positive), sometimes S. epidermidis (coagulase negative, implant-associated)

Specimen: Pus/wound swab

Steps:

1. Direct Microscopy (Gram stain):
  • Gram-positive cocci in clusters ("grape-like bunches")
  • PMNs present (pus cells)
  • No spores, no capsule
2. Culture:
  • Blood agar: Golden/cream-yellow colonies, beta hemolysis (zone of clearing)
  • MacConkey agar: Small pink/colorless colonies (ferments lactose weakly)
  • Mannitol salt agar (selective): S. aureus ferments mannitol --> YELLOW colonies; others = red colonies
  • Chapman's medium: Same principle as mannitol salt agar
3. Identification Tests:
TestS. aureusS. epidermidis
CoagulasePOSITIVENegative
Mannitol (anaerobic)POSITIVENegative
DNasePositiveNegative
Protein APresentAbsent
Beta hemolysinOften presentAbsent
Coagulase test (KEY):
  • Slide coagulase: Detects bound coagulase (clumping factor) - fast screening
  • Tube coagulase: Detects free coagulase - definitive (clot in tube in 1-4 hrs)
4. Antibiogram (crucial):
  • Kirby-Bauer disc diffusion
  • Check for MRSA (Methicillin-Resistant S. aureus) - use oxacillin/cefoxitin disc
  • MIC testing for serious infections
5. Phage typing:
  • Epidemiological tracing of hospital outbreaks

B. S. aureus - Four Important Diseases

DiseaseToxin/MechanismFeatures
1. Furunculosis/Wound infectionDirect invasion, coagulase, hemolysinsLocalized abscess, pus
2. Toxic Shock Syndrome (TSS)TSST-1 (superantigen)Fever, rash, hypotension, multi-organ failure
3. Scalded Skin Syndrome (SSSS)Exfoliative toxin A and BDiffuse bullous desquamation; Nikolsky sign positive; mainly children
4. Food poisoningEnterotoxins A-E (heat stable)Nausea, vomiting (no fever), rapid onset

C. Staphylococcal Food Poisoning

Toxin: Preformed enterotoxin (types A-E, most commonly type A)
  • Heat stable (survive 100°C for 30 min - unlike the bacteria)
  • Not destroyed by reheating food - key epidemiological point
Foods commonly involved: Cream pastries, custards, salads, processed meats, dairy products (handled by carrier)
Source: Nasal carriers/skin lesions of food handlers (10-15% population carry S. aureus)
Pathogenesis:
Contaminated food left at room temperature (20-37°C) for >4 hours
        |
S. aureus multiplies and produces ENTEROTOXIN (preformed)
        |
Toxin ingested (bacteria may die, but toxin remains)
        |
Toxin acts on vagal afferents in gut --> stimulates vomiting center
        |
RAPID ONSET (1-6 hours): profuse vomiting, nausea, cramps, diarrhea
        |
Self-limited (12-24 hours), NO FEVER (since no invasion)
Key features that distinguish it:
  1. Short incubation (1-6 hours) - shortest of all food poisonings
  2. No fever (toxin-mediated, not infection)
  3. Vomiting predominates over diarrhea
  4. Self-limiting (12-24 hours)
Diagnosis:
  • Clinical (short incubation + no fever + vomiting)
  • Culture food and patient's stool/vomit for S. aureus
  • Phage typing of isolates from food and patient
  • Detect enterotoxin by ELISA/RIA in food

6. CORYNEBACTERIUM DIPHTHERIAE

A. Pathogenicity of Diphtheria

Organism: Gram-positive, non-motile, non-spore-forming, pleomorphic rod with metachromatic granules; arranged in "Chinese letter" / palisade arrangement
Virulence factor: Diphtheria toxin (encoded by tox gene of bacteriophage beta/corynephage)

Mechanism of Toxin Action:

Tox gene (bacteriophage beta) --> Diphtheria toxin (2 fragments: A and B)
        |
Fragment B: BINDS to heparin-binding EGF receptor on host cell
        |
Toxin-receptor complex internalized
        |
Fragment A: ACTIVE unit - ADP-ribosylates EF-2 (Elongation Factor 2)
        |
Inhibits protein synthesis IRREVERSIBLY
        |
CELL DEATH in heart, nerves, adrenal glands, kidneys
ONE molecule of toxin can kill a cell (most potent toxins known)

Local Disease (Throat):

  • Toxin + bacteria --> necrosis of epithelial cells
  • Fibrinous exudate + necrotic cells + RBCs + WBCs form PSEUDOMEMBRANE
  • Pseudomembrane: grayish-white, tough, adherent, bleeds on removal ("leathery")
  • Located on tonsils/pharynx; can extend to larynx (croup, airway obstruction)

Systemic Effects (Toxin spread via bloodstream):

  1. Myocarditis (most serious complication) - occurs in Week 2-3; arrhythmias, heart block
  2. Neuropathy - palatal palsy first (nasal regurgitation), then ciliary paralysis, then peripheral neuritis
  3. Adrenal hemorrhage - rare

B. Metachromatic Granules (Volutin Granules/Babes-Ernst granules)

  • Composed of polymetaphosphate (storage form of phosphate)
  • Stain red/violet with blue dyes (metachromasia)
  • Located at poles of the cell (POLAR GRANULES)
Demonstration:
  1. Albert's stain: Granules stain blue-black, rest of cell green
  2. Neisser's stain: Granules stain brown-black, cell body yellow
  3. Ponder's stain / Toluidine blue: Granules appear red against blue background
Significance:
  • Characteristic of C. diphtheriae
  • Helps differentiate from C. pseudodiphtheriticum (no granules)
  • Also seen in C. xerosis but less prominent

C. Toxigenicity Tests

1. Elek's Immunodiffusion Test (In vitro - Gold Standard)

Principle: Antitoxin-impregnated filter paper placed in agar; test strain inoculated perpendicular to filter paper. If toxin produced, precipitin line forms at point where antigen and antibody meet (immunodiffusion).
Tellurite blood agar plate:
|__________________________________|
|       ← Antitoxin paper strip →  |
|  TEST STRAIN  |  POSITIVE CONTROL |
|  streaked     |  streaked         |
|  perpendicular to strip           |
|___________________________________|
Incubate 37°C, 48 hrs

POSITIVE: White precipitin line of identity between test and control
NEGATIVE: No precipitin line

2. Guinea Pig Virulence Test (In vivo)

  • Inject test culture filtrate into one guinea pig + culture filtrate + antitoxin into another
  • Toxin-producing strain: first GP dies (necrosis); second GP (protected by antitoxin) survives

3. PCR

  • Detects tox gene directly - most specific and sensitive
  • Used in reference laboratories

4. Cell culture cytotoxicity test

  • Cell lines (Vero/HeLa) inoculated with toxin; cytopathic effect (CPE) observed

7. VIBRIO CHOLERAE

A. Gardner and Venkataraman's Classification

V. cholerae classified based on O antigen (somatic) groups:
GroupFeatures
Group I (O1)Causes epidemic/pandemic cholera
Group II (O139)Causes epidemic cholera (Bengal strain, 1992)
Non-O1, Non-O139Sporadic diarrhea only; no epidemic potential
Group O1 further divided into:
SubgroupBiotypeSerotype
O1Classical OR El TorOgawa (AB), Inaba (AC), Hikojima (ABC)

B. Classical vs. El Tor Vibrios - Differences

FeatureClassical BiotypeEl Tor Biotype
1. HemolysisNON-hemolyticHEMOLYTIC (El Tor hemolysin)
2. Voges-Proskauer (VP) testNegativePOSITIVE
3. Polymyxin B sensitivitySENSITIVE (inhibited)RESISTANT
4. Group IV phageSENSITIVERESISTANT
5. Agglutination of chicken RBCNegativePOSITIVE (hemagglutination)
6. Disease severityMore severe (pure cholera gravis)Milder; more carrier state
7. Carrier rateLowHIGH (>100 carriers per case)
8. PandemicCaused 1st-6th pandemicsCauses 7th pandemic (ongoing)

C. Laboratory Diagnosis of Cholera

Specimen: Rice-water stool (massive, watery, "rice-water" appearance = flecks of mucus)

1. Direct Examination:

  • Wet film (Hanging drop preparation): "Shooting star" / darting motility of vibrios
  • Gram stain: Gram-negative curved "comma-shaped" rods
  • Dark field microscopy: Rapid, reveals characteristic motility

2. Culture:

  • TCBS (Thiosulfate Citrate Bile Salt Sucrose) agar: Selective; V. cholerae = yellow sucrose-fermenting colonies
  • Alkaline peptone water (APW) pH 8.6: Enrichment medium (vibrios prefer alkaline); vibrios grow as surface pellicle in 6-8 hrs
  • GYNB (Gelatin Yeast extract NaCl Broth): Alternative enrichment
APW enrichment --> subculture to TCBS --> yellow colonies --> confirm biochemically

3. Serology (Confirmation):

  • Slide agglutination with Poly O1 antiserum --> agglutination = V. cholerae O1
  • Further type with Ogawa and Inaba monospecific antisera
  • If non-agglutinating: test with O139 antiserum

4. Biochemical Tests:

  • Oxidase: POSITIVE
  • String test: POSITIVE (bacteria suspended in 0.5% sodium deoxycholate forms viscous string)
  • TSI: Alkaline slant/Acid butt, no H2S, no gas
  • Cholera Red reaction (Indole + nitroso compound): Pink-red color

5. Rapid Tests:

  • Dipstick (crystal violet cholera dipstick): Field use
  • Co-agglutination, immunofluorescence

D. Halophilic Vibrios

Definition: Vibrios that REQUIRE NaCl for growth (salt-loving); unlike V. cholerae (grows without NaCl)
Two Important Examples:

1. Vibrio parahaemolyticus

  • Requires 2-4% NaCl
  • Found in coastal sea water, seafood (crabs, prawns, oysters)
  • Causes: Explosive watery diarrhea (seafood gastroenteritis), occasionally dysentery
  • Kanagawa Phenomenon: Virulent strains produce Thermostable Direct Hemolysin (TDH) which causes beta-hemolysis on Wagatsuma agar (human blood agar) but NOT on sheep blood agar = Kanagawa POSITIVE = virulent

2. Vibrio vulnificus

  • Requires NaCl for growth
  • Found in warm coastal waters, raw oysters
  • Causes: Severe wound infections (exposure to seawater), primary septicemia (oyster ingestion in liver disease patients)
  • High mortality (>50%) in immunocompromised/liver disease patients

Kanagawa Phenomenon:

V. parahaemolyticus strains
        |
        |---> Kanagawa POSITIVE (TDH producing)
                 | Beta-hemolysis on Wagatsuma agar (human RBCs)
                 | Associated with HUMAN DISEASE
                 | Virulent
        |
        |---> Kanagawa NEGATIVE (no TDH)
                 | No hemolysis on Wagatsuma agar
                 | Environmental strains
                 | Not virulent for humans (usually)

8. CHLAMYDIA TRACHOMATIS

A. Four Diseases Caused by C. trachomatis

SerotypeDisease
A, B, Ba, CTrachoma (chronic follicular keratoconjunctivitis; leading cause of preventable blindness)
D-KUrogenital infections: NGU, cervicitis, PID, epididymitis; Inclusion conjunctivitis (neonatal/adult); Infant pneumonia
L1, L2, L2a, L3Lymphogranuloma venereum (LGV) - tropical ulcerative STD
Summary: TRACHOMA (A,B,C) + GENITAL (D-K) + LGV (L1-L3)

B. Laboratory Diagnosis of Trachoma (most common/exam-asked)

Specimen: Conjunctival scraping (NOT swab - must get epithelial cells)
1. Direct Smear - Giemsa Stain:
  • Intracytoplasmic inclusion bodies: Halberstaedter-Prowazek (HP) bodies
  • Blue-staining mass in cytoplasm of conjunctival epithelial cells
  • Inclusion bodies cap the nucleus
2. Iodine Stain:
  • Inclusions stain brown (glycogen-containing matrix)
  • Specific for C. trachomatis (unlike C. psittaci and C. pneumoniae which do NOT contain glycogen)
3. Cell Culture (Gold Standard):
  • McCoy cells (irradiated) or HeLa 229 cells
  • Inoculate with specimen, centrifuge to enhance infectivity
  • Stain with iodine or immunofluorescence after 48-72 hours
  • See intracytoplasmic inclusions
4. Direct Immunofluorescence (DIF):
  • Fluorescent-labeled monoclonal antibody against MOMP (Major Outer Membrane Protein)
  • Elementary bodies (EBs) fluoresce apple-green
  • Rapid, sensitive
5. ELISA:
  • Detects chlamydial LPS antigen
  • Less sensitive than DIF but useful for screening
6. NAAT (Nucleic Acid Amplification Test) - Most sensitive:
  • PCR, LCR (Ligase Chain Reaction), SDA
  • Can use urine, cervical/urethral swabs
  • Standard of care for genital chlamydia
7. Serology:
  • Micro-immunofluorescence (MIF): Detects type-specific antibodies
  • Complement fixation: Genus-specific; useful for LGV (>1:64 diagnostic)

C. Chlamydia vs. Virus - Differences

FeatureChlamydiaVirus
1. Cell wallPresent (peptidoglycan-like; no muramic acid in C. trachomatis)ABSENT
2. Both DNA and RNAYES (both present simultaneously)Either DNA OR RNA (not both)
3. RibosomesPRESENT (70S prokaryotic)ABSENT
4. Binary fissionYES (reproduces by binary fission as RB)NO (assembles from components)
5. Susceptibility to antibioticsSENSITIVE (tetracyclines, macrolides)RESISTANT (not affected by antibiotics)
6. Size300-500 nm (large for bacteria)20-300 nm (variable)
7. Metabolic activityPartial (cannot synthesize ATP - "energy parasite")None of its own
8. Developmental cycleYES - Elementary Body (EB) + Reticulate Body (RB)NO such cycle

Chlamydia Developmental Cycle (Diagram):

ELEMENTARY BODY (EB) - Infectious form
        |  
        | Enters host cell by endocytosis
        |  
RETICULATE BODY (RB) - Metabolically active, non-infectious
        |  
        | Multiplies by binary fission (6-8 times)
        | inside phagosome (resists lysosomal fusion)
        |  
INCLUSION body forms (collection of RBs, then condenses to EBs)
        |  
        | Cell lyses
        |  
Mature EBs released --> infect new cells
        |  
(Cycle = 48-72 hours)
EB: Small (0.3 µm), rigid, electron-dense, metabolically inert, infectious RB: Large (1 µm), fragile, metabolically active, NON-infectious, replicates

Quick Comparison Tables for Exam

Non-Suppurative Sequelae Summary:

FeatureRheumatic FeverAGN
FollowingPharyngitis ONLYPharyngitis + Skin infection
Latent period2-4 weeks1-6 weeks
MechanismMolecular mimicry (autoimmune)Immune complex (Type III)
M typesMultipleM12 (pharyngitis), M49 (skin)
PreventionPenicillin prophylaxisTreat promptly
RecurrenceYES - strep reinfectionNO (rare)

Classical vs. El Tor vs. O139:

FeatureClassicalEl TorO139 (Bengal)
Pandemic1st-6th7th (current)Potential 8th
HemolysinNegativePositivePositive
CapsuleAbsentAbsentPRESENT
VaccinePartial protectionPartial protectionNOT protected by O1 vaccine

Source: Murray PR et al. Medical Microbiology 9e; Jawetz Melnick & Adelberg Medical Microbiology 28e. Apurb Shastri MUHS Pattern presentation.

All 8 topics covered with MUHS exam-oriented depth, tables, flow diagrams, pathogenesis, lab diagnosis, and key differentials. Good luck for your exams!
This is a shared conversation. Sign in to Orris to start your own chat.